## Answer
(model generated chain of thought explanation)

Firstly, let's understand what post-exposure prophylaxis (PEP) is in this context. PEP refers to the administration of antiretroviral medications to prevent HIV infection after potential exposure to the virus.

The medications prescribed for PEP include tenofovir, emtricitabine, and raltegravir. These drugs work by inhibiting the reverse transcriptase enzyme, which is essential for viral replication.

Reverse transcriptase is an enzyme that converts the viral RNA into DNA, allowing the virus to replicate inside the host cell. By inhibiting this enzyme, the antiretroviral medications effectively prevent the virus from replicating and eventually leading to infection.

Now, let's consider how these medications affect the maximum reaction rate (Vm) and Michaelis constant (Km) of the viral reverse transcriptase:

- **Maximum Reaction Rate (Vm):** The Vm is a measure of the maximum velocity at which the enzyme can convert substrate into product. In the context of antiretroviral therapy, the Vm is often reduced due to the presence of covalent inhibitors that bind to the active site of the enzyme and prevent it from converting substrate into product.

- **Michaelis Constant (Km):** The Km is a measure of the affinity of the enzyme for its substrate. In other words, it's a measure of how tightly the enzyme binds to its substrate. The Km value can be affected by various factors, including the presence of inhibitors that alter the enzyme's conformation or binding site.

Given this information, let's analyze the options:

A. Vm and Km will both decrease: This is incorrect because the Vm would likely increase due to the presence of covalent inhibitors, while the Km might remain unchanged or even be affected by the inhibitor binding.

B. Vm will decrease, Km will increase: This option seems plausible as the inhibitor (tenofovir) could alter the enzyme's conformation and binding site, leading to an increase in Km but a potential decrease in Vm due to the covalent inhibition.

C. Vm will stay the same, Km will increase: This is incorrect because the presence of inhibitors would likely lead to changes in both Km and Vm.

D. Vm and Km will both increase: This option seems unlikely as the inhibitor (tenofovir) would not cause a significant increase in Km but could potentially